Professional Documents
Culture Documents
Guidelines in Evaluating The Validity and Applicability of A Research Study
Guidelines in Evaluating The Validity and Applicability of A Research Study
1. What is the research design? 2. What is the level of quality of the Research study according to the U.S. Preventive Services Task Force? 3. Are the results of the study valid? a. Randomization b. Follow-up (80% or better) c. Blinding of the clinicians, patients, research personnels (the more blinding the better d. Baseline similarities (established at the start of the trial) 4. What are the results of the research study? 5. Will the results help in caring for my patient? 6. What is the Level of Recommendation according to the U.S. Preventive Services Task Force
Ideas, Editorials, Opinions Exchange of ideas-Subjective Animal Research Trial that involves animals as samples Test Tube research trial that tests a substance in a test tube
LEVEL of EVIDENCE
Level I Evidence obtained from at least one properly designed randomized controlled trial Level II-1 Evidence obtained from well-designed controlled trials without randomization Level II-2 Evidence obtained from well-designed cohort or case-control analytic studies, preferably from more than one center or research group. Level II-3 Evidence obtained from multiple time series with or without the intervention. Dramatic results in uncontrolled trials might also be regarded as this type of evidence. Level III Opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees.
LEVEL OF RECOMMENDATION
The U.S. Preventive Services Task Force (USPSTF) assigns one of five letter grades to each of its recommendations (A, B, C, D, or I). What the Grades Mean and Suggestions for Practice A The USPSTF recommends the service. There is high certainty that the net benefit is substantial. Offer or provide this service. B The USPSTF recommends the service. There is high certainty that the net benefit is moderate or there is moderate certainty that the net benefit is moderate to substantial. Offer or provide this service. C Clinicians may provide this service to selected patients depending on individual circumstances. However, for most individuals without signs or symptoms there is likely to be only a small benefit from this service. Offer or provide this
service only if other considerations support the offering or providing the service in an individual patient. D The USPSTF recommends against the service. There is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits. Discourage the use of this service. I The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of the service. Evidence is lacking, of poor quality, or conflicting, and the balance of benefits and harms cannot be determined. Read the clinical considerations section of USPSTF Recommendation Statement. If the service is offered, patients should understand the uncertainty about the balance of benefits and harms.